This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Institut Curie, National Institute of Health and Medical Research, Université De Versailles—saint-Quentin-En-Yvelines. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 162 
1 out of 1,853 
1 out of 25 Years Active: 2025
Title: Amanda Bortolini Silveira: Innovator in Genetic Mutation Detection
Introduction
Amanda Bortolini Silveira is a prominent inventor based in Paris, France. She has made significant contributions to the field of genetics, particularly in the detection of mutations in microsatellite sequences. Her innovative approach has the potential to enhance the accuracy of genetic testing and diagnostics.
Latest Patents
Amanda holds a patent for a method for detecting a mutation in a microsatellite sequence. This patent, which is a crucial advancement in genetic research, involves a process that subjects a DNA sample to a digital polymerase chain reaction (PCR) in the presence of a specialized PCR solution. This method aims to improve the detection of mutations, which can be vital for various medical applications.
Career Highlights
Throughout her career, Amanda has worked with esteemed institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Amanda has collaborated with notable colleagues, including Charlotte Proudhon and Amélie Kasperek. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Amanda Bortolini Silveira is a trailblazer in the field of genetic research, with her patent and collaborations highlighting her commitment to advancing science. Her work continues to inspire future innovations in genetic mutation detection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile